Fu, Liwu

KRAS Mutation: From Undruggable to Druggable in Cancer

Huang, L., Guo, Z., Wang, F., & Fu, L. (2021) · Signal Transduction and Targeted Therapy

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 1,127

Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs

An, S., & Fu, L. (2018) · EBioMedicine

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 363

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

Zhang, Y., Li, C., Xia, C., Wah To, K. K., Guo, Z., Ren, C., Wen, L., Wang, F., Fu, L., & Liao, N. (2022) · Cell Communication and Signaling

Drug Transport and Resistance MechanismsAntibiotic Resistance in Bacteria

Cited by 33

Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo

Zeng, F., Wang, F., Zheng, Z., Chen, Z., Wah To, K. K., Zhang, H., Han, Q., & Fu, L. (2020) · Acta Pharmaceutica Sinica B

Drug Transport and Resistance MechanismsAntibiotic Resistance in Bacteria

Cited by 26